Kenan İzgi

The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer

Çağrı Şakalar, Kenan İzgi, Banu İskender et al. · Tumor Biology · 2015 · 71 citations

Connective tissue and its growth factor CTGF distinguish the morphometric and molecular remodeling of the bladder in a model of neurogenic bladder

Cengiz Z. Altuntas, Firouz Daneshgari, Kenan İzgi et al. · American Journal of Physiology-Renal Physiology · 2012 · 44 citations · Full text

Immunodeficiencies, Immunology, Immune Regulation +28

Chronic pelvic allodynia is mediated by CCL2 through mast cells in an experimental autoimmune cystitis model

Fuat Bicer, Cengiz Z. Altuntas, Kenan İzgi et al. · American Journal of Physiology-Renal Physiology · 2014 · 43 citations · Full text

Inflammation, Cytokine, Allergy +13

Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial–mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis

Banu İskender, Kenan İzgi, Halit Canatan · Molecular and Cellular Biochemistry · 2016 · 40 citations

Tumor Biology, Oncology, Oncogenic Agent +12

Uroplakin Peptide-Specific Autoimmunity Initiates Interstitial Cystitis/Painful Bladder Syndrome in Mice

Kenan İzgi, Cengiz Z. Altuntas, Fuat Bicer et al. · PLoS ONE · 2013 · 37 citations · Full text